A provider evaluates a patient on day 5 of trimethoprim-sulf…
A provider evaluates a patient on day 5 of trimethoprim-sulfamethoxazole therapy for a urinary tract infection. The patient reports new onset of low-grade fever, generalized malaise, and a diffuse erythematous rash involving the trunk. Vital signs are stable. What is the most appropriate next step in management?